Inogen shows solid B2B growth, but guidance and margin issues hurt sentiment. Learn why INGN stock is a speculative play with long-term growth potential.
Carlyn Zwarenstein writes about science for Salon. She's also the author of a book about drugs, pain, and the consolations of art, On Opium: Pain, Pleasure, and Other Matters of Substance.
This study cohort was made up of 71.3% U.K. patients with bronchiectasis. Referral to pulmonary rehabilitation was presented to 19.6% of patients. Prior to being diagnosed with bronchiectasis ...
By Alexandra Alter Our crime columnist recommends books starring hard-boiled investigators who are ready to travel down the meanest streets to root out the darkest truths. By Sarah Weinman In a ...
The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...
If you click on links we provide, we may receive compensation. The South Carolina Gamecocks coach says her latest book is “my chance to honor the people who have built me up” Carly Tagen-Dye ...
“Sunrise on the Reaping,” by Suzanne Collins, explores the devastating story of Haymitch Abernathy, a mentor in the original “Hunger Games” novels. By Jennifer Harlan Our columnist on ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Monday, March 17, 2025. Let’s take a ...
Sorting through them after the move, Cooper, 81, discovered an artifact — a library book 99 years past due.“I was looking through the books and found one about (building) toys for boys and ...
Christopher Summerfield’s book “These Strange New Minds” offers a lucid intellectual history of AI and argues that chatbots are more than clever copycats. Joshua Hammer’s “The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback